BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

CARBOPLATIN Pages on BioPortfolio:

Biotechnology News CARBOPLATIN Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/CARBOPLATIN-news.htm...

BioPortfolio - Carboplatin
Updated Data from Initial Cohort Shows Nine of 14 Evaluable Patients Receiving Bavituximab in Combination with Carboplatin + Paclitaxel Achieved an ...
http://www.bioportfolio.com/indepth/Carboplatin.html...

Biotechnology News Telik Search
today announced the publication of the positive results from a Phase 1-2a multicenter, dose-ranging study of TELCYTA in combination with carboplatin and
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - Oncolytics Biotech Inc. - Oncolytics Biotech(R) Inc ...
Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial on BioPortfolio.com ... paclitaxel/carboplatin for patients with advanced cancers were presented at ...
http://www.bioportfolio.com/news/Oncolytics_Biotech(R)_Inc._...

Biotechnology News Drug Toxicity Search
Currently, paclitaxel and carboplatin given every three weeks is considered ... Currently, paclitaxel and carboplatin given every three weeks is considered ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

Lung Cancer: Eli Lilly's Affinitac to challenge the cytotoxics
Bristol-Myers Squibb (BMS) is a dominant force in the US lung cancer market by virtue of having Paraplatin (carboplatin), Platinol (cisplatin) and Taxol ...
http://www.bioportfolio.com/news/datamonitor_36.htm...

BioPortfolio Biotechnology BioNews : live article
CLN-8: Phase Ib/II trial evaluating intravenous belinostat in combination with paclitaxel and carboplatin. Phase Ib dose-escalation results on 23 patients ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

Gynaecological cancer treatment enters new era of patient-tailored ...
16 Oct 2009 ... Treating women with relapsed platinum-sensitive ovarian cancer with combined carboplatin and pegylated liposomal doxorubicin prolongs ...
http://www.bioportfolio.com/biotech_news/ESGO_1.htm...

BioPortfolio Biotechnology BioNews : live article
Two-thirds of the patients will receive intravenous ZYBRESTAT plus carboplatin and paclitaxel, and the other third will receive carboplatin and paclitaxel ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioPortfolio News: - Oncolytics Biotech(R) Inc. Reaches...
All patients will receive treatment every three weeks (21 day cycles) with paclitaxel and carboplatin and will also receive, on a blinded basis, ...
http://www.bioportfolio.com/news/Oncolytics_Biotech(R)_Inc._...

Results from other life science and pharmaceutical sites:

Carboplatin - Wikipedia, the free encyclopedia
5 Aug 2009 ... Carboplatin is a chemotherapy drug used against some forms of cancer (mainly ovarian carcinoma, lung, head and neck cancers). ...
http://en.wikipedia.org/wiki/Carboplatin...

Carboplatin: MedlinePlus Drug Information
Provides information on usage, precautions, side effects and brand names when available. Data provided by government agencies and health-related ...
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a695017.htm...

ACS :: Cancer Drug Guide: carboplatin
Carboplatin is a platinum chemotherapy drug that belongs to a group of drugs known as alkylating agents. It stops the growth of cancer cells, ...
http://www.cancer.org/docroot/CDG/content/CDG_carboplatin.as...

BioMed Central | Full text | DNA damage induced by cis- and ...
DNA damage after a one day treatment with cis- or carboplatin correlated well with the .... DNA damage induced by the crosslinkers cis- and carboplatin was
...
http://www.biomedcentral.com/1471-2407/9/359...

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
RESULTS: The 12-month rates of progression-free survival were 24.9% with gefitinib and 6.7% with carboplatin-paclitaxel. The study met its primary
objective ...
http://www.ncbi.nlm.nih.gov/pubmed/19692680...

Carboplatin--R&S PharmChem Co.,Ltd.
Carboplatin ( KAR-boe-pla-tin) belongs to the group of medicines known as alkylating agents. It is used to treat cancer of the ovaries. ...
http://www.rspharmchem.com/carboplatin.htm...

Radiotherapy versus single-dose carboplatin in adjuvant treatment ...
After good results in initial studies with one injection of carboplatin, we undertook a large randomised trial to compare the approaches of radiotherapy ...
http://www.ncbi.nlm.nih.gov/pubmed/16039331...

A randomised study of carboplatin vs sequential ifosfamide ...
In a study designed to compare response rates of patients with stage III epithelial ovarian carcinoma to ifosfamide and carboplatin, 152 patients were
...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=19...

Paclitaxel-carboplatin alone or with bevacizumab for non-small ...
CONCLUSIONS: The addition of bevacizumab to paclitaxel plus carboplatin in the treatment of selected patients with non-small-cell lung cancer has a ...
http://www.ncbi.nlm.nih.gov/pubmed/17167137...

Phase II Trial of Carboplatin and Paclitaxel in Papillary Renal ...
8 Jul 2009 ... Abstract and Introduction: Cytotoxic chemotherapy has not been well investigated in non-clear-cell renal cell carcinoma (RCC), ...
http://www.medscape.com/viewarticle/705131...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.